People with diabetes are among those Americans at high risk for dangerous complications of COVID. If you or a loved one has diabetes and tests positive for COVID-19, you may be eligible for COVID-19 treatments that are now FDA-approved and available nationwide. Studies show that these available therapies—called “monoclonal antibodies”—are most effective in those who are recently diagnosed with COVID, though they may also be effective for others. Anyone with COVID-19 who has diabetes should call your health care provider to ask whether a monoclonal antibody treatment is appropriate for you.

What Are Monoclonal Antibody Treatments?

Monoclonal antibodies have been used effectively and safely for different conditions since 1986. They boost our ability to respond to bacteria, viruses, and other harmful cells. Like your body’s own antibodies, they recognize germs that cause disease and neutralize them. 

Learn more about monoclonal antibody treatments.

Since the COVID-19 pandemic began, three monoclonal antibody treatments have been approved by the FDA for use against COVID-19 under an “Emergency Use Authorization.” Research trials have found them to be highly effective, and at least one available therapy has recently been shown to be effective in many patients against new COVID-19 variants. 

Find out more from the FDA about available therapies, or to get information to share with your health care provider.

Monoclonal antibody treatments for COVID-19 are administered as infusions at sites equipped to accommodate patients who are COVID-19-positive. They can be obtained through a doctor's order or a physician’s request for “compassionate use.” If your health care provider believes that a monoclonal antibody therapy is appropriate for you, you and the provider should know where you can get this therapy in your area. 

Get the latest on locations where monoclonal antibody infusions are being administered for COVID-19 patients.